Asciminib Hydrochloride

Records for this ingredient, by country (identity only).

ATC L01EA06 · 3 markets · 10 records

Asciminib Hydrochloride 3 markets · 10 records Forms

Filters

MarketAU 5 SG 3 FR 2

Strength

AU 5 records · 3 shown of 3 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

43.24 mgtabletSCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack+1SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet bottle unknown
21.62 mgtabletSCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack+1SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet bottle unknown
108.1 mgtabletSCEMBLIX asciminib 100 mg film coated tablet bottle unknown

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

40 mgtabletSCEMBLIX also in FR
20 mgtabletSCEMBLIX also in FR
100 mgtabletSCEMBLIX

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

40 mgtabletSCEMBLIX 20 mg, comprimé pelliculé also in SG
20 mgtabletSCEMBLIX 20 mg, comprimé pelliculé also in SG

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.